PTEN-Long-mediated molecular therapy: current evidences and future perspectives.
- DOI
- 10.1016/j.bcp.2026.118471
- Published
- 2026 Sep 14
- Container
- Biochemical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.118471,
title = {PTEN-Long-mediated molecular therapy: current evidences and future perspectives.},
author = {Sun T and Han X and Wang Y and Ren Y and Cheng T and Meng W and Feng X and Jiao M and Jiang S and Qin Y and An Y},
year = {2026},
journal = {Biochemical pharmacology},
doi = {10.1016/j.bcp.2026.118471},
url = {https://doi.org/10.1016/j.bcp.2026.118471}
}RIS
TY - JOUR TI - PTEN-Long-mediated molecular therapy: current evidences and future perspectives. AU - Sun T AU - Han X AU - Wang Y AU - Ren Y AU - Cheng T AU - Meng W AU - Feng X AU - Jiao M AU - Jiang S AU - Qin Y AU - An Y PY - 2026 JO - Biochemical pharmacology DO - 10.1016/j.bcp.2026.118471 UR - https://doi.org/10.1016/j.bcp.2026.118471 ER -
APA
T, S., X, H., Y, W., Y, R., T, C., W, M., X, F., M, J., S, J., Y, Q., & Y, A. (2026). PTEN-Long-mediated molecular therapy: current evidences and future perspectives.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2026.118471
Source records
- pubmed · retrieved 2026-09-25T17:08:01.970Z